Higher-Level TB Research to Begin at NEIDL Boston Public Health Commission Gives Go-Ahead

in Featured, In The News, Lab Updates
October 31st, 2013

Original article from: BU Today, posted on October 31, 2013. by Rich Barlow

BU’s National Emerging Infectious Diseases Laboratories will begin doing tuberculosis research at a higher biosafety level in the coming months, following approval of the work by the Boston Public Health Commission. The research will be transferred from another lab on the Medical Campus.

TB researchers Igor Kramnik, a School of Medicine professor of medicine and director of NEIDL’s Aerobiology Core, and James Galagan, a College of Engineering professor of biomedical engineering and NEIDL associate director of systems biology, have also received approval from BU’s Institutional Biosafety Committee (ISB) to begin preparing for Biosafety Level 3 (BSL-3) research at NEIDL. BSL-3 research at the lab was green-lighted by a federal court in September.

Read the full article in BU Today